Document Type : Original Research
Authors
- Ramin Jokari 1
- Zahra Mahyari 2
- Mohammad Javad Moulodi 2, 3
- Seyyed Mohammad Fatemi Ghiri 2
- Hadi Tajalizadeh 2, 3
- Ali Loloee Jahromi 2
- Alireza Nakhostin 2
- Gholamreza Abdollahifard 4
- Hossein Parsaei 5, 6
1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2 Basamad Azma Novin Pars Co. Ltd, Innovation and Acceleration Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Substance Abuse and Mental Health Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
5 Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
6 Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Background: Diabetes is a global concern, with an estimated 2 million individuals expected to be affected by the condition by 2024. Non-invasive glucose monitoring devices can greatly enhance patient care and management.
Objective: This study aimed to develop an instrument capable of non-invasively measuring blood glucose levels using an infrared transmitter and receiver, with data processing performed by a dedicated processor.
Material and Methods: This analytical study develops a glucometer that incorporates a power supply, a light source, a light detector, a sampler, and signal processing components to enable non-invasive glucose measurements. The instrument was calibrated using sugar solution samples with known glucose concentrations. It was then tested using serum samples from diabetic patients with accuracy, which was evaluated using Clarke’s grid analysis.
Results: Testing of the designed glucometer revealed that 83% of the serum samples fell within zone A of Clarke’s grid analysis, indicating high accuracy. The remaining 17% of samples were classified in zone B, with no samples falling in zones C, D, or E.
Conclusion: The developed glucometer demonstrated higher accuracy in measuring glucose concentrations above 200 mg/dl. Despite the use of serum samples in this experiment, 83% of the results were located in zone A leads to the capability of non-invasively measuring blood glucose levels. Further studies are required to validate the device’s accuracy in a larger population and assess its utility in clinical practice.
Highlights
Hossein Parsaei (Google Scholar)
Keywords
- Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377-90. doi: 10.1038/s41581-020-0278-5. PubMed PMID: 32398868. PubMed PMCID: PMC9639302.
- American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917-928. doi: 10.2337/dci18-0007. PubMed PMID: 29567642. PubMed PMCID: PMC5911784.
- DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. 2018;391(10138):2449-62. doi: 10.1016/S0140-6736(18)31320-5. PubMed PMID: 29916386. PubMed PMCID: PMC6661119.
- Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239-51. doi: 10.1016/S0140-6736(17)30058-2. PubMed PMID: 28190580.
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513-30. doi: 10.1016/S0140-6736(16)00618-8. PubMed PMID: 27061677. PubMed PMCID: PMC5081106.
- Evans M. The UK Prospective Diabetes Study. 1998;352(9144):1932-3. doi: 10.1016/S0140-6736(05)60422-9. PubMed PMID: 9863807.
- Group AC. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72. doi: 10.1056/NEJMoa0802987. PubMed PMID: 18539916.
- Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-39. doi: 10.1056/NEJMoa0808431. PubMed PMID: 19092145.
- Esenaliev RO, Larin KV, Larina IV, Motamedi M. Noninvasive monitoring of glucose concentration with optical coherence tomography. Opt Lett. 2001;26(13):992-4. doi: 10.1364/ol.26.000992. PubMed PMID: 18040511.
- Barton SJ, Tang Z, Hennelly BM. Predicting the effect of changing an optical element in a given Raman micro-spectrometer. In Optics in Health Care and Biomedical Optics XI. China: SPIE; 2021. p. 312-8.
- Oliver NS, Toumazou C, Cass AE, Johnston DG. Glucose sensors: a review of current and emerging technology. Diabet Med. 2009;26(3):197-210. doi: 10.1111/j.1464-5491.2008.02642.x. PubMed PMID: 19317813.
- Yadav L, Manjhi JA. Noninavsive biosensor for diabetes monitoring. Asian J Pharm Clin Res. 2014;7(3):206-11.
- Vajhadin F, Mazloum-Ardakani M, Amini A. Metal oxide-based gas sensors for the detection of exhaled breath markers. Med Devices Sens. 2021;4(1):e10161. doi: 10.1002/mds3.10161. PubMed PMID: 33615149. PubMed PMCID: PMC7883254.
- Clarke WL. The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther. 2005;7(5):776-9. doi: 10.1089/dia.2005.7.776. PubMed PMID: 16241881.